Drawing for TUTEVA

USPTO serial 90563235

TUTEVA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
MEIER, SHARON A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TUTEVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian J. Focarino

Brian J. Focarino COOLEY LLP1299 PENNSYLVANIA AVENUE, N.W.SUITE 700WASHINGTON, DC 20004

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposesABANDONED—
010Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipientsABANDONED—
042Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysisABANDONED—
044Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patientsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 28, 2022MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Sep 28, 2022ABN5ABANDONMENT - AFTER PUBLICATION—
Sep 28, 2022EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Apr 26, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 13, 2022ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 17, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 17, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 17, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 10, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 13, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 27, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 27, 2021DOCKASSIGNED TO EXAMINER—
Jun 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 9, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance